May 18 Drug wholesaler McKesson Corp reported a 4.4 percent rise in quarterly revenue, helped by strength in its pharmaceutical distribution and services business.
Net income attributable to McKesson rose to $3.59 billion, or $16.76 per share, in the fourth quarter ended March 31, from $431 million, or $1.88 per share, a year earlier.
The latest quarter earnings included a pre-tax net gain of $3.9 billion related to the creation of the Change Healthcare joint venture.
Revenue rose to $48.71 billion from $46.68 billion, the company said on Thursday.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Sriraj Kalluvila)
Tanker firm Frontline says no longer pursuing DHT or other acquisitions
OSLO, June 26 Oslo-listed oil tanker firm Frontline is no longer pursuing an acquisition of New York-listed competitor DHT Holdings and is not working on any other acquisitions either, Frontline's CEO told Reuters on Monday.
BRIEF-Inno-Gene says units reach agreement with Illumina over patent dispute
* SAID ON FRIDAY THAT ITS UNITS, CENTRUM BADAN DNA SP. Z O.O AND MEDGENETIX SP. Z O.O., REACHED SETTLEMENT WITH THE COMPANY ILLUMINA INC. CONCERNING VIOLATION OF INTELLECTUAL PROPERTY OF ITS PATENT